Target intelligence / Profile preview

Influenza virus hemagglutinin stem region (HA stem) (HA stem)

Target
HA stem
Molecular classification
Viral surface glycoprotein, Class I viral fusion protein, Other
01

Overview

The influenza virus hemagglutinin (HA) stem region is a highly conserved domain of the primary surface glycoprotein responsible for viral entry into host cells (Nature, 2018). While the HA head region undergoes frequent antigenic drift, the stem region (primarily composed of the HA2 subunit) remains relatively invariant across diverse influenza A and B strains (Science, 2015). This conservation makes it a critical target for the development of universal influenza vaccines and broadly neutralizing antibodies (bnAbs) (Cell, 2019). Biologically, the stem region mediates the fusion of the viral envelope with the host endosomal membrane through a pH-triggered conformational change (PNAS, 2016). Therapeutic agents targeting this region, such as monoclonal antibodies like MEDI8852 or small molecules like Umifenovir, function by stabilizing the pre-fusion conformation (The Lancet Infectious Diseases, 2020). By sterically hindering the fusion machinery, these drugs prevent the release of the viral genome into the host cytoplasm (Nature Communications, 2019). This mechanism effectively neutralizes the infection across multiple viral subtypes, offering a broader range of protection than traditional vaccines (Journal of Virology, 2018).

Other names
Hemagglutinin stalk regionHA2 subunitInfluenza HA stem domainConserved stem regionHemagglutinin fusion region
02

Mechanism of action

The primary mechanism involves binding to the conserved stem region to sterically block the pH-induced conformational change required for membrane fusion, thereby preventing the release of the viral genome into the host cell (Nature Communications, 2019).

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Immunodominance of the HA head region masking the stemLow natural immunogenicity of the stalk domainTheoretical risk of antibody-dependent enhancement (ADE)Potential for viral escape mutations in the conserved region
06

Interacting drugs

Umifenovir

6 more in the full profile.

07

Biomarkers

Stem-specific antibody titers (ELISA)HA2-binding IgG levelsCompetition with CR9114 or FI6v3 antibodies

Beyond the preview

Go deeper on Influenza virus hemagglutinin stem region (HA stem) (HA stem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza virus hemagglutinin stem region (HA stem) (HA stem).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call